Journal: Hepatology Communications

Article Title: Short-term costs of alcohol-associated hepatitis care in different clinical settings

doi: 10.1097/HC9.0000000000000634

Figure Lengend Snippet: Patient characteristics and comorbidity at the time of alcohol-associated hepatitis (AH) diagnosis

Article Snippet: However, this estimate is lower than the 30-day IP costs for congestive heart failure ($147,392; SD=$225,659) and chronic obstructive pulmonary disease ($113,040; SD=$169,215) reported by Optum during the same study period.

Techniques: Biomarker Discovery

Journal: Hepatology Communications

Article Title: Short-term costs of alcohol-associated hepatitis care in different clinical settings

doi: 10.1097/HC9.0000000000000634

Figure Lengend Snippet: (A) Clustered comorbidities by correlation; (B) Prevalence of each cluster in 3 care settings. Abbreviations: Anemdef, deficiency anemias; CHF, congestive heart failure; CBVD, cerebrovascular disease; Chronic pulm, chronic pulmonary disease; HTN, hypertension; liver_msev, moderate to severe liver disease; Neuro, neurological disorders; Pulmon circ, pulmonary circulation disease; PVD, peripheral vascular disease.

Article Snippet: However, this estimate is lower than the 30-day IP costs for congestive heart failure ($147,392; SD=$225,659) and chronic obstructive pulmonary disease ($113,040; SD=$169,215) reported by Optum during the same study period.

Techniques:

Journal: Hepatology Communications

Article Title: Short-term costs of alcohol-associated hepatitis care in different clinical settings

doi: 10.1097/HC9.0000000000000634

Figure Lengend Snippet: Factors associated with the post-AH medical costs in the 3 care setting. Abbreviations: AH, alcohol-associated hepatitis; CBVD, clusters of cerebrovascular disease; CHF, congestive heart failure; HTN, hypertension; LD, liver disease; LOS, length of stay; PVD, peripheral vascular disease.

Article Snippet: However, this estimate is lower than the 30-day IP costs for congestive heart failure ($147,392; SD=$225,659) and chronic obstructive pulmonary disease ($113,040; SD=$169,215) reported by Optum during the same study period.

Techniques:

Journal: BMC Public Health

Article Title: Effects of confounding and effect-modifying lifestyle, environmental and medical factors on risk of radiation-associated cardiovascular disease

doi: 10.1186/s12889-024-18701-9

Figure Lengend Snippet: Unadjusted or adjusted estimated excess relative risk of cardiovascular diseases in various therapeutically and diagnostically treated groups, exposed at moderate or high radiation doses and high dose rates. All analyses adjust for age

Article Snippet: Case–control study nested within ESCaRa breast cancer cohort study , Baaken et al. [ ] , Heart , BMI, chemotherapy, endocrine therapy, previous CVD , Myocardial infarction, angina pectoris, congestive heart failure, dysrhythmia, valvular heart disease, or mortality from cardiac infarction (ICD10 I21-I23), chronic IHD (ICD10 I25.0-I25.9), acute IHD (ICD10 I21.0-I24.9), congestive heart failure (ICD10 I50.0-I50.9), angina pectoris (ICD10 I20.0-I20.9), cardiac arrest (ICD10 I46), dysrhythmia/conduction disorder (ICD10 I44.0-I49.9), vitium cordis (ICD10 I34.0-I37.9) , Incidence , -0.01 (-0.06 to 0.05) , -0.01 (-0.06 to 0.05) , , Analysis adjusted for chemotherapy, endocrine therapy and BMI. Unadjusted ERR also presented.

Techniques: Activity Assay, Modification, Biomarker Discovery, Control